Martine De Herdt

122 Chapter 4 Supplementary table 2: Investigated oral squamous cell carcinoma cell lines culture conditions. Cell line T (°C) CO2 (%) Medium Supplements SCC-4 37 5 DMEM/F12 (Life Technologies™) 10% Fetal Calf Serum (Life Technologies™), 1% Penicillin/Streptomycin (Life Technologies™) and 400ng/ml Hydrocortisone (Sigma-Aldrich®) SCC-9 37 5 DMEM/F12 (Life Technologies™) 10% Fetal Calf Serum (Life Technologies™), 1% Penicillin/Streptomycin (Life Technologies™), 400ng/ml Hydrocortisone (Sigma-Aldrich®), 2.5mM L-Glutamine (Sigma-Aldrich®) and 0.5 mM Sodium pyruvate (Sigma-Aldrich®) SCC-25 37 5 DMEM/F12 (Life Technologies™) 10% Fetal Calf Serum (Life Technologies™), 1% Penicillin/Streptomycin (Life Technologies™), 400ng/ml Hydrocortisone (Sigma-Aldrich®), 2.5mM L-Glutamine (Sigma-Aldrich®) and 0.5 mM Sodium pyruvate (Sigma-Aldrich®) UM-SCC-14C 37 5 DMEM (Life Technologies™) 10% Fetal Calf Serum (Life Technologies™) and 1% Penicillin/Streptomycin (Life Technologies™) BICR-16 37 5 DMEM (Life Technologies™) 10% Fetal Calf Serum (Life Technologies™) and 1% Penicillin/Streptomycin (Life Technologies™) CAL-27 37 5 DMEM (Life Technologies™) 10% Fetal Calf Serum (Life Technologies™) and 1% Penicillin/Streptomycin (Life Technologies™)

RkJQdWJsaXNoZXIy MTk4NDMw